The IBD interactome: an integrated view of aetiology, pathogenesis and therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature reviews: Gastroenterology & hepatology

• Publication date

  2017-08-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrgastro.2017.110PMID 28831186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blocking Smad 7 restores TGF-b 1 signaling in chronic inflammatory bowel disease

  2018cited by this paper
• Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease

  2016cited by this paper
• Writ large: Genomic dissection of the effect of cellular environment on immune response

  2016cited by this paper
• Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

  2016cited by this paper
• Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC

  2016cited by this paper
• Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants

  2016cited by this paper
• The Host Shapes the Gut Microbiota via Fecal MicroRNA.

  2016cited by this paper
• Exposing the exposures responsible for type 2 diabetes and obesity

  2016cited by this paper
• Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease

  2016cited by this paper
• Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

  2016cited by this paper
• Endophenotype Network Models: Common Core of Complex Diseases

  2016cited by this paper
• Genomic analyses identify molecular subtypes of pancreatic cancer

  2016cited by this paper
• Going global by adapting local: A review of recent human adaptation

  2016cited by this paper
• Electronic Sorting of Immune Cell Subpopulations Based on Highly Plastic Genes

  2016cited by this paper
• Transgenerational inheritance: Models and mechanisms of non–DNA sequence–based inheritance

  2016cited by this paper
• Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility

  2016cited by this paper
• Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

  2016cited by this paper
• Immunopathogenesis of IBD: current state of the art

  2016cited by this paper
• Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

  2016cited by this paper
• Genomic Classification and Prognosis in Acute Myeloid Leukemia.

  2016cited by this paper
• Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.

  2016cited by this paper
• Gene-environment interplay

  2016cited by this paper
• Therapeutic genome editing: prospects and challenges

  2015cited by this paper
• Widespread macromolecular interaction perturbations in human genetic disorders.

  2015cited by this paper
• A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.

  2015cited by this paper
• High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics

  2015cited by this paper
• Exposome in IBD: Recent Insights in Environmental Factors that Influence the Onset and Course of IBD

  2015cited by this paper
• The cellular composition of the human immune system is shaped by age and cohabitation

  2015cited by this paper
• Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6

  2015cited by this paper
• Integrative analysis of 111 reference human epigenomes

  2015cited by this paper
• Multiple Molecular Data Sets and the Classification of Adult Diffuse Gliomas.

  2015cited by this paper
• A MicroRNA Signature in Pediatric Ulcerative Colitis: Deregulation of the miR-4284/CXCL5 Pathway in the Intestinal Epithelium

  2015cited by this paper
• Beyond the Genome

  2015cited by this paper
• Beyond the genome

  2015cited by this paper
• Precision medicine--personalized, problematic, and promising.

  2015cited by this paper
• Identifying personal microbiomes using metagenomic codes

  2015cited by this paper
• Genetics of Inflammatory Bowel Diseases.

  2015cited by this paper
• The genetic architecture of inflammatory bowel disease: past, present and future

  2015cited by this paper
• MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.

  2015cited by this paper
• Elucidating Compound Mechanism of Action by Network Perturbation Analysis.

  2015cited by this paper
• Early life dynamics of the human gut virome and bacterial microbiome in infants

  2015cited by this paper
• The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2

  2015cited by this paper
• Systems biology in inflammatory bowel diseases: ready for prime time

  2014cited by this paper
• Artificial sweeteners induce glucose intolerance by altering the gut microbiota

  2014cited by this paper
• Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

  2014cited by this paper
• Circular RNAs: diversity of form and function

  2014cited by this paper
• CytoCom: a Cytoscape app to visualize, query and analyse disease comorbidity networks

  2014cited by this paper
• Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci

  2014cited by this paper
• The microbiome in inflammatory bowel disease: current status and the future ahead.

  2014cited by this paper
• A mathematics for medicine: The Network Effect

  2014cited by this paper
• Hygiene hypothesis in inflammatory bowel disease

  2014cited by this paper
• Cytokines in inflammatory bowel disease

  2014cited by this paper
• Human genetics shape the gut microbiome.

  2014cited by this paper
• Complex diseases require complex therapies

  2013cited by this paper
• Chromatin modifiers and remodellers: regulators of cellular differentiation

  2013cited by this paper
• Pattern discovery and cancer gene identification in integrated cancer genomic data

  2013cited by this paper
• Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.

  2013cited by this paper
• Inflammatory Bowel Disease in Chinese Children: A Multicenter Analysis Over a Decade from Shanghai

  2013cited by this paper
• VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies

  2013cited by this paper
• A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

  2013cited by this paper
• Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics

  2013cited by this paper
• Extensive Variation in Chromatin States Across Humans

  2013cited by this paper
• Beyond GWASs: illuminating the dark road from association to function.

  2013cited by this paper
• A Novel Approach to Detect Cumulative Genetic Effects and Genetic Interactions in Crohn’s Disease

  2013cited by this paper
• MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

  2013cited by this paper
• Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine.

  2013cited by this paper
• iPOP goes the world: integrated personalized Omics profiling and the road toward improved health care.

  2013cited by this paper
• Transcriptional regulation and its misregulation in disease.

  2013cited by this paper
• Discovering causal pathways linking genomic events to transcriptional states using Tied Diffusion Through Interacting Events (TieDIE)

  2013cited by this paper
• Variation and Genetic Control of Protein Abundance in Humans

  2013cited by this paper
• Personalizing medicine for autoimmune and inflammatory diseases

  2013cited by this paper
• Integrative Subtype Discovery in Glioblastoma Using iCluster

  2012cited by this paper
• The gut microbiota in IBD

  2012cited by this paper
• Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals

  2012cited by this paper
• iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data

  2012cited by this paper
• Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

  2012cited by this paper
• A travel guide to Cytoscape plugins

  2012cited by this paper
• Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

  2012cited by this paper
• Innovation: Metabolomics: the apogee of the omics trilogy

  2012cited by this paper
• Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

  2012cited by this paper
• Genome‐wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway

  2012cited by this paper
• Widespread RNA and DNA Sequence Differences in the Human Transcriptome

  2011cited by this paper
• Abundant pleiotropy in human complex diseases and traits.

  2011cited by this paper
• Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.

  2011cited by this paper
• Crohn disease: A current perspective on genetics, autophagy and immunity

  2011cited by this paper
• DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status

  2011cited by this paper
• Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

  2011cited by this paper
• Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling

  2011cited by this paper
• Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome.

  2011cited by this paper
• Integration, warehousing, and analysis strategies of Omics data.

  2011cited by this paper
• Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides

  2011cited by this paper
• Genomics Is Not Enough

  2011cited by this paper
• Genomewide association studies and assessment of the risk of disease.

  2010cited by this paper
• The NIH Roadmap Epigenomics Mapping Consortium

  2010cited by this paper
• Upregulation of DNA Methyltransferase–Mediated Gene Silencing, Anchorage-Independent Growth, and Migration of Colon Cancer Cells by Interleukin-6

  2010cited by this paper
• Tackling Chronic Disease in Europe: Strategies, Interventions and Challenges

  2010cited by this paper
• Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks

  2010cited by this paper
• Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM

  2010cited by this paper
• Unveiling the role of network and systems biology in drug discovery.

  2010cited by this paper
• CellMiner: a relational database and query tool for the NCI-60 cancer cell lines

  2009cited by this paper

• The effects of TPGS-modified liposomal ginger extract in the treatment of acetic acid-induced ulcerative colitis in rats.

  2026cites this paper
• Research Advances and Model Selection Considerations in Mouse Models of Ulcerative Colitis

  2026cites this paper
• Interleukin Signatures as Prognostic Biomarkers in Ulcerative Colitis: From Immune Pathways to Clinical Prediction.

  2026cites this paper
• Association between temperature and global incidence of inflammatory bowel disease

  2026cites this paper
• Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn’s Disease: An Observational Study

  2025cites this paper
• [The characteristics of pediatric-onset inflammatory bowel disease based on our 20-year-long study].

  2025cites this paper
• Microbiota-derived metabolites in inflammatory bowel disease

  2025cites this paper
• Incorporating Real‐World Variability in Clinical IBD Research

  2025cites this paper
• Passive smoking exposure and incidence and disease outcomes of inflammatory bowel disease: a systematic review and meta-analysis

  2025cites this paper
• Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis

  2025cites this paper
• Prevalence and Severity of Periodontitis in Patients with Ulcerative Colitis: A Case–Control Study

  2025cites this paper
• Genetic Predisposition and Nutritional Interactions in Gastroenterology: A Review of European Clinical Recommendations

  2025cites this paper
• Cadmium co-ingestion promotes systemic nanoplastics distribution in mice via multi-level intestinal barrier compromise.

  2025cites this paper
• Neonatal microbiome in the multiomics era: development and its impact on long-term health

  2025cites this paper
• Visualisation of research hotspots in the surgical management of inflammatory bowel disease based on the web of science database

  2025cites this paper
• Cholesterol Sulfate: Pathophysiological Implications and Potential Therapeutics

  2025cites this paper
• Single-cell nanocapsules of gut microbiota facilitate fecal microbiota transplantation

  2025cites this paper
• A Review on Luteolin as a Promising Agent against Ulcerative Colitis: From Molecular Insights to Therapeutic Applications

  2025cites this paper
• The Frequency and Characteristics of Inflammatory Bowel Disease in Pediatric Patients with Hirschsprung's Disease: A Case-Control Study

  2025cites this paper
• Stem cell therapy for inflammatory bowel disease: clinical trial landscape and emerging strategies.

  2025cites this paper
• The expression of ferroptosis-related proteins GPX4 and PTGS2 in colonic tissues of pediatric Crohn’s disease

  2025cites this paper
• Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota

  2025cites this paper
• Protective and therapeutic potentials of Trichinella spiralis larval antigen in murine induced colitis

  2025cites this paper
• Piezo1 promotes colitis progression by modulating the Nrf2/NF-κB/NLRP3 signaling pathway.

  2025cites this paper
• Dysregulation of cellular metabolism within the gut-brain axis is associated with behavioural changes in chronic intestinal inflammation

  2025cites this paper
• Dysregulated immunometabolism in gut inflammation

  2025cites this paper
• Neutrophils disrupt the intestinal barrier via IL-22/TGF-β/Mmp9 axis in the zebrafish model of inflammatory bowel disease.

  2025cites this paper
• Advanced Hydrogel Platforms for Inflammatory Bowel Disease Therapy: Smart Drug Delivery, Immunomodulation, and Remodeling of the Gut Microenvironment

  2025cites this paper
• Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease

  2025cites this paper
• A Sequential Release Micro-nano System for Colitis Therapy via Gut Microbiota and Immune Regulation.

  2025cites this paper
• Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development

  2025cites this paper
• Expert Recommendations to Standardise Transcriptomic Analysis in Inflammatory Bowel Disease Clinical Trials.

  2025cites this paper
• “Remodeling the intestinal immune microenvironment”: immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease

  2025cites this paper
• Unlocking the power of swine gut bacteria: newly isolated Blautia strain and its metabolites inhibit the replication of Salmonella Typhimurium in macrophages and alleviate DSS-induced colitis in mice

  2025cites this paper
• Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease

  2025cites this paper
• TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis

  2025cites this paper
• MAPK signaling mediated intestinal inflammation induced by endoplasmic reticulum stress and NOD2

  2025cites this paper
• Application of machine learning in the discovery of antimicrobial peptides: exploring their potential for ulcerative colitis therapy

  2025cites this paper
• Causal Relationship Between Mitochondrial Characteristics and Inflammatory Bowel Disease and Its Subtypes: Evidence for Mendelian Randomization

  2025cites this paper
• Antimicrobial peptide DP7 alleviates dextran sulfate sodium (DSS)‐induced colitis via modifying gut microbiota and regulating intestinal barrier function

  2025cites this paper
• Unveiling the Cuproptosis in Colitis and Colitis-Related Carcinogenesis: A Multifaceted Player and Immune Moderator

  2025cites this paper
• Transcription factor ELF-1 protects against colitis by maintaining intestinal epithelium homeostasis

  2025cites this paper
• Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease.

  2025cites this paper
• The Multifaceted Role of Sirtuins in Inflammatory Bowel Diseases.

  2025cites this paper
• Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset

  2025cites this paper
• Quantitative Alterations in Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  2025cites this paper
• Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease

  2025cites this paper
• Colon‐targeted complement C5a1 receptor inhibition using pH‐sensitive nanoparticles ameliorates experimental colitis

  2025cites this paper
• Causal relationship between serum metabolites and Crohns disease: A bidirectional two-sample Mendelian randomization study

  2025cites this paper
• Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis

  2025cites this paper
• Unravelling γδ T-cell dysregulation in the gut and its implications for immune-mediated diseases

  2025cites this paper
• Modified Cellulose for Intestinal Health.

  2025cites this paper
• Relief of EGFR/FOS-downregulated miR-103a by loganin alleviates NF-kappaB-triggered inflammation and gut barrier disruption in colitis

  2025cites this paper
• A nomogram for predicting the risk of Clostridioides difficile infection in children with ulcerative colitis: development and validation

  2025cites this paper
• Peptostreptococcus Anaerobius enhances dextran sulfate sodium-induced colitis by promoting nf-κB-NLRP3-Dependent macrophage pyroptosis

  2024cites this paper
• Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites.

  2024cites this paper
• STARD7 maintains intestinal epithelial mitochondria architecture, barrier integrity, and protection from colitis

  2024cites this paper
• Emerging Technologies in Inflammatory Bowel Disease: A Minireview on Future Treatment Modalities.

  2024cites this paper
• An Attack on All Fronts—Extinguishing the Fire of IBD with an Integrative Approach

  2024cites this paper
• Serum electrolyte abnormalities in cats with chronic inflammatory enteropathy

  2024cites this paper
• Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB Signaling

  2024cites this paper
• Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8+ T cells

  2024cites this paper
• Diagnostic delay in inflammatory bowel diseases in a German population

  2024cites this paper
• Lipopolysaccharide-regulated RNF31/NRF2 axis in colonic epithelial cells mediates homeostasis of the intestinal barrier in ulcerative colitis.

  2024cites this paper
• Inhibition of Transmural Inflammation in Crohn's Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors.

  2024cites this paper
• Targeting the IL-23 Pathway in Inflammatory Bowel Disease.

  2024cites this paper
• Deubiquitinase USP14 is upregulated in Crohn's disease and inhibits the NOD2 pathway mediated inflammatory response in vitro

  2024cites this paper
• Navigating the complexities of drug development for inflammatory bowel disease

  2024cites this paper
• Single-cell transcriptomics reveals activation of endothelial cell and identifies LHPP as a potential target in ulcerative colitis

  2024cites this paper
• Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis

  2024cites this paper
• DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells

  2024cites this paper
• Oral administration of RDP58 ameliorated DSS-induced colitis in intestinal microbiota dependent manner.

  2024cites this paper
• ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease.

  2024cites this paper
• Prevotella histicola ameliorates DSS-induced colitis by inhibiting IRE1α-JNK pathway of ER stress and NF-κB signaling.

  2024cites this paper
• Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova: A Randomized, Double-blinded, Placebo-controlled Clinical Trial (the PROCTO Trial).

  2024cites this paper
• Memristor-based Bayesian spiking neural network for IBD diagnosis

  2024cites this paper
• Alterations in tryptophan metabolism and de novo NAD+ biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation

  2024cites this paper
• The Role of Vitamin D and Vitamin D Receptor Gene Polymorphisms in the Course of Inflammatory Bowel Disease in Children

  2024cites this paper
• Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases.

  2024cites this paper
• Payload‐free protein nanoparticles target inflamed colons to restore intestinal barrier integrity for effectively treating inflammatory bowel diseases

  2024cites this paper
• Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease

  2024cites this paper
• Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine

  2024cites this paper
• Peripheral and intestinal T lymphocyte subsets in dogs with chronic inflammatory enteropathy

  2024cites this paper
• Nanotechnology for Targeted Inflammatory Bowel Disease Therapy: Challenges and Opportunities.

  2024cites this paper
• Shikonin delivery nano system based on calcium alginate for targeted therapy of inflammatory bowel disease by modulating macrophage polarization

  2024cites this paper
• Considerations in Paediatric and Adolescent Inflammatory Bowel Disease

  2024cites this paper
• Effects of polyphenolic maqui (Aristotelia chilensis) extract on the inhibition of NLRP3 inflammasome and activation of mast cells in a mouse model of Crohn’s disease-like colitis

  2024cites this paper
• An Inflammatory Bowel Diseases Integrated Resources Portal (IBDIRP)

  2024cites this paper
• Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics

  2024cites this paper
• Oral creatine-modified selenium-based hyaluronic acid nanogel mediated mitochondrial energy recovery to drive the treatment of inflammatory bowel disease

  2024cites this paper
• Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol

  2024cites this paper
• Prebiotics for induction and maintenance of remission in ulcerative colitis.

  2024cites this paper
• Baseline Data and Measurement Instruments Reported In Observational Studies In Inflammatory Bowel Disease: Results From A Systematic Review.

  2024cites this paper
• Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019.

  2024cites this paper
• Inhibition of Piezo1 Ameliorates Intestinal Inflammation and Limits the Activation of Group 3 Innate Lymphoid Cells in Experimental Colitis

  2023cites this paper
• Patient education interventions for the management of inflammatory bowel disease

  2023cites this paper
• IBD and Motherhood: A Journey through Conception, Pregnancy and Beyond

  2023cites this paper
• Inhibition of GSDMD-mediated pyroptosis triggered by Trichinella spiralis intervention contributes to the alleviation of DSS-induced ulcerative colitis in mice

  2023cites this paper
• Enteric neuro-immune interactions in intestinal health and disease.

  2023cites this paper
• Early Ileocecal Resection for Crohn’s Disease

  2023cites this paper